A consortium of private equity funds acquired a controlling stake in a leading Turkish pharmaceutical group. Cristina Audran-Proca represented the private equity funds in the acquisition and the subsequent refinancing of the pharmaceutical group's existing facilities from a top-tier Turkish bank.
2012